Background Recurrent respiratory papillomatosis is a rare but morbid disease caused by
human papillomavirus (HPV) types 6 and 11. Infection is preventable through HPV …

Background: Improving the quality of physicians' recommendations for human
papillomavirus (HPV) vaccination is critical to addressing low coverage. Thus, we sought to …

Oncogenic human papillomavirus (HPV) infection is the cause of nearly all cervical cancers
and a proportion of other anogenital and oropharyngeal cancers. A bivalent vaccine …

Prophylactic vaccines have been found to be highly effective in preventing infection and pre-
invasive and invasive cervical, vulvovaginal and anal disease caused by the vaccine types …

Introduction Adolescence is a time of physical, emotional and social transitions that have
implications for health. In addition to being at high risk for HIV, young key populations (YKP) …

Background: We estimated the prevalence and incidence of 14 human papillomavirus (HPV)
types (6/11/16/18/31/33/35/39/45/51/52/56/58/59) in cervicovaginal swabs, and the …

Oral squamous cell carcinoma (SCC) is a prevalent malignant disease worldwide,
especially so in Taiwan. Early-or even preclinical-stage detection is critical for reducing …

Background: A quadrivalent human papillomavirus (HPV4) type 6/11/16/18 vaccine
(GARDASIL/SILGARD®) has been licensed in many countries around the world for the …

* Quadrivalent HPV vaccine was licensed in 2006 (information available at http://www. cdc.
gov/mmwr/preview/mmwrhtml/rr5602a1. htm) and the bivalent HPV vaccine was licensed in …

The two licensed bivalent and quadrivalent human papillomavirus (HPV) L1 (the major
papillomavirus virion protein) virus-like particle (VLP) vaccines are regarded as safe …